Opening book details…
About this Medicine article
Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features by Yang, Xiaochuan ;Sen, Filiz ;Geyer, Mark B. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Yang, Xiaochuan ;Sen, Filiz ;Geyer, Mark B.
- Publisher
- Elsevier ; Elsevier Limited; Amsterdam: Elsevier; Elsevier BV (ISSN 2213-0489)
- Published
- 2019
- Field
- Medicine (Health Sciences)
More by Yang, Xiaochuan ;Sen, Filiz ;Geyer, Mark B.
Browse all works by Yang, Xiaochuan ;Sen, Filiz ;Geyer, Mark B.